One week ago St Jude Medical (NYSE:STJ) was downgraded from Outperform to Market Perform at BMO Capital. St Jude Medical shares are selling at $38.55, 3.4% above the $37.30 price point of one week ago.
Potential upside of 7.1% exists for St Jude Medical, based on a current level of $39.01 and analysts' average consensus price target of $41.78. The stock should discover initial support at its 200-day moving average (MA) of $38.35 and subsequent support at its 50-day MA of $35.81.
St. Jude Medical, Inc. develops, manufactures, and distributes medical devices for the worldwide cardiovascular market. The Company serves patients and its health care customers with products and services including heart valves, cardiac rhythm management systems, specialty catheters, and other cardiovascular devices.
In the past 52 weeks, shares of St Jude Medical have traded between a low of $30.25 and a high of $44.80 and are now at $39.01, which is 29% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.2% while the 50-day MA has remained constant.